ISIS PHARMACEUTICAL
ISIS PHARMACEUTICAL operates in Diversified Metals & Mining.
ISIS PHARMACEUTICAL (ISI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.174x
Based on the latest financial reports, ISIS PHARMACEUTICAL (ISI) has a cash flow conversion efficiency ratio of -0.174x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-114.99 Million) by net assets (€662.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ISIS PHARMACEUTICAL - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how ISIS PHARMACEUTICAL's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ISIS PHARMACEUTICAL Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ISIS PHARMACEUTICAL ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ribbon Acquisition Corp Rights
NASDAQ:RIBBR
|
N/A |
|
JULIUS BAER GRP N (JGE.SG)
STU:JGE
|
N/A |
|
Fold Holdings, Inc. Warrant
NASDAQ:FLDDW
|
-0.026x |
|
ARCHER-DANIELS MID. - Dusseldorf Stock Exchang
DU:ADM
|
0.021x |
|
Ovoca Gold PLC
IR:OVXA
|
-0.136x |
|
NEW YORK TIMES -A- (NYT.SG)
STU:NYT
|
0.068x |
|
Gecina Nom
STU:GI6A
|
0.019x |
|
Turbo Mech Bhd
KLSE:5167
|
0.013x |
Annual Cash Flow Conversion Efficiency for ISIS PHARMACEUTICAL (2016–2023)
The table below shows the annual cash flow conversion efficiency of ISIS PHARMACEUTICAL from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €386.69 Million | €-307.51 Million | -0.795x | -66.05% |
| 2022-12-31 | €572.89 Million | €-274.37 Million | -0.479x | -1300.05% |
| 2021-12-31 | €771.74 Million | €30.80 Million | 0.040x | -17.35% |
| 2020-12-31 | €743.28 Million | €35.89 Million | 0.048x | -76.47% |
| 2019-12-31 | €1.68 Billion | €345.72 Million | 0.205x | -59.59% |
| 2018-12-31 | €1.19 Billion | €602.89 Million | 0.508x | +22.10% |
| 2017-12-31 | €418.72 Million | €174.15 Million | 0.416x | +136.94% |
| 2016-12-31 | €99.56 Million | €-112.11 Million | -1.126x | -- |